查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2095240

心臟疾病診斷影像設備市場－2026-2032年全球市場預測

Coronary Heart Disease Diagnostic Imaging Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟疾病診斷影像設備市場規模將成長至 76 億美元，複合年成長率為 7.41%。

主要市場統計數據
基準年 2025 46.1億美元
預計年份：2026年 49.3億美元
預測年份 2032 76億美元
複合年成長率 (%) 7.41%

冠狀動脈疾病診斷影像設備在缺血性心臟疾病的早期檢測、風險分層、治療計畫制定和術後評估中發揮核心作用。此領域的設備包括非侵入性和侵入性影像方式，例如電腦斷層掃描血管攝影（CT冠動脈攝影術）、磁振造影（MRI）、核醫系統、心臟超音波圖、血管內超音波、光學相干斷層掃描（OCT）以及導管檢查室使用的光學同調斷層造影。全球心血管疾病負擔沉重，心血管疾病仍是世界衛生組織（WHO）統計的全球首要死因，因此，對這些設備的需求日益成長。此外，臨床上也迫切需要更精確、更降低手術風險地識別冠狀動脈狹窄、斑塊負荷、心肌灌注受損、室壁運動異常和微血管功能障礙等問題。市場環境受多種因素影響，例如：基於指南的解剖和功能成像技術的引入、微創診斷的日益普及、檢測器技術的進步、輻射暴露的減少、床邊超音波、混合成像以及數位化工作流程的整合。此外，在醫療保健系統中，早期診斷、縮短住院時間和高效利用導管室資源備受重視，用於診斷冠狀動脈疾病的影像設備在醫院、診斷中心、循環系統診所和門診機構中被視為策略重點。

診斷影像領域的變革性變化

在冠狀動脈疾病影像學領域，結構性變革正在發生，從單一模式、以手術主導的診斷​​轉向整合式、個人化的影像路徑。冠狀動脈CT血管攝影檢查）憑藉更高的空間解析度、更快的掃描速度和更低的輻射暴露，正擴大用於評估低至中度風險族群中疑似冠狀動脈疾病的病例。心臟磁振造影（MRI）在評估心肌活力、灌注、纖維化以及鑑別診斷發炎性心肌病方面持續拓展其應用，而核子醫學在評估功能性缺血方面仍然至關重要，尤其是在臨床需要進行負荷試驗和灌注定量時。在介入影像學方面，血管內超音波（IVUS）和光學同調斷層掃描（OCT）透過改善病灶特徵、支架最佳化和斑塊形態評估，增強了影像導引冠狀動脈介入治療的作用。這種轉變也體現在科技的進步中。光子計數CT、先進的超音波探頭、固體檢測器、PET/CT和SPECT/CT混合系統、雲端影像管理以及互通性標準正在重新定義採購標準。同時，以價值為導向的醫療模式的推進要求醫療服務提供者減少不必要的侵入性血管造影術，最佳化適應症標準，並根據診斷效用、患者安全、工作流程效率和後續臨床影響來選擇影像工具。

人工智慧對冠狀動脈成像的累積影響。

人工智慧正透過改善影像擷取、重建、分割、解讀、報告和工作流程優先排序，對冠狀動脈疾病診斷影像設備的整個生態系統產生累積影響。在CT和MRI中，人工智慧驅動的重建能夠縮短掃描時間、降低雜訊並最佳化輻射計量。自動計算冠狀動脈鈣化評分、斑塊定量、心腔分割和心肌灌注分析提高了可重複性，並支持一致的臨床報告。在心臟超音波圖，機器學習工具有助於對影像進行分類、估算射血分數、分析應變並提高影像質量，有助於減少檢查者之間的差異。在核子醫學領域，人工智慧正被應用於衰減校正、灌注缺陷檢測和風險分類，而介入影像平台也擴大將自動管腔和支架測量功能整合到血管內超音波（IVUS）和光學相干斷層掃描（OCT）中。人工智慧的影響遠不止於診斷領域。人工智慧驅動的分診可以識別高風險檢查、簡化影像解讀等待名單，並產生與電子健康記錄整合的結構化報告。然而，人工智慧的實施需要經過臨床檢驗的性能、透明的演算法、網路安全措施、資料管治、監管部門的批准、與現有PACS和心血管資訊系統的整合，以及臨床醫生的信任。隨著證據的積累，人工智慧有望不再作為一項獨立功能，而是作為核心層整合到冠狀動脈成像工作流程中。

全球冠狀動脈成像技術應用的關鍵區域性見解

在亞太地區，冠狀動脈疾病診斷影像技術的應用主要得益於大規模的患者群體、不斷增加的心臟代謝風險因素、三級心臟護理中心的擴張，以及公共和私人機構對先進CT、MRI、超音波和導管檢查室基礎設施的投資。日本、中國、印度、韓國和澳洲是先進心臟影像影像技術的主要用戶，但農村和資源匱乏地區仍存在醫療資源取得方面的差距。在歐洲，完善的心血管診療路徑、積極推行的輻射暴露減少方案、心臟CT和MRI方面的專業技術，以及公共醫療體系中以品質為導向的採購體系，都是推動技術應用的重要因素，儘管西歐、中歐和東歐在獲取新平台方面存在差異。北美地區的特點是成熟的醫療保險報銷系統、積極推行的指南、先進的醫院網路，以及血管內影像技術在冠狀動脈CT血管攝影檢查、運動負荷試驗、心臟超音波圖、核子醫學和複雜冠狀動脈介入治療中的廣泛應用。在拉丁美洲，巴西、墨西哥和其他都市區醫療中心對心臟診斷的投資正在增加，但醫療資源分配不均、設備集中在大城市以及預算限制等問題影響診斷方法的選擇。非洲面臨的醫療資源分配限制最為嚴重，冠狀動脈影像服務主要集中在都市區和私人醫療機構。儘管如此，隨著人們對非傳染性疾病管理的重視程度不斷提高，對心臟超音波圖、CT 以及適用於基礎設施有限的擴充性診斷解決方案的需求也在不斷成長。在中東，透過對三級醫療機構、專科心臟中心和數位醫療基礎設施的投資，尤其是在高所得的海灣國家，醫療資源分配正在取得進展，但擴大全部區域的醫療服務覆蓋範圍取決於人力資源開發和轉診網路的成熟度。

針對特定族群的關鍵見解正在影響冠狀動脈疾病的影像診斷。

北約成員國與北美和歐洲的多個先進醫療體系重疊，這些國家的採購重點日益側重於韌性供應鏈、網路安全、數位成像的互通性以及跨醫院網路提供標準化心血管護理。七國集團（G7）國家普遍擁有較高的實證冠狀動脈影像技術應用率、廣泛的先進診斷方法，並高度重視人工智慧檢驗、輻射計量管理、互通性和臨床結果。金磚國家（BRICS）的部署模式整體呈現多樣性。中國和印度正在進行大規模的產能擴張，巴西和南非致力於彌合公立和私立醫療體系之間的服務差距，俄羅斯則擁有專業的心血管中心，儘管先進影像技術的區域分佈並不均衡。歐盟透過法律規範、跨境技術標準、醫療技術評估以及強調安全性、適宜性和品質保證的基於指南的診療路徑，為冠狀動脈診斷成像提供了一個高度結構化的環境。在東協地區，冠狀動脈疾病診斷影像檢查的普及主要得益於快速的都市化進程、私人醫療網路的擴張以及各國為改善非傳染性疾病診療所做的努力。新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國在CT、MRI、核醫和介入影像檢查等方面的普及程度不一。在海灣合作理事會（GCC）國家，心血管疾病的高風險人群、對醫院基礎設施的大力投資以及專業的心臟病診療項目，推動了包括心臟CT、MRI、心臟超音波圖以及與導管室相結合的影像技術在內的先進影像平台的應用。

主要國家冠狀動脈疾病影像診斷設備的發展趨勢

在中國，受CT、超音波、血管造影術以及人工智慧輔助影像技術日益普及的需求推動，公立醫院和大型心臟中心的冠狀動脈影像能力正在迅速擴展。在美國，冠狀動脈CT血管攝影檢查、心臟超音波圖、核子醫學、心臟磁振造影、血管攝影、血管造影術（IVUS）和光學相干斷層掃描（OCT）等技術已被廣泛應用，這得益於專業的心臟中心、完善的認證體係以及人工智慧驅動的工作流程的快速整合。日本長期以來在CT技術應用、心血管影像研究以及老年患者的診療路徑方面保持優勢。同時，在印度，心臟超音波圖、CT和導管介入術在冠狀動脈評估中發揮重要作用，並透過大都會圈醫院網路和診斷連鎖機構不斷擴大其應用範圍。德國、英國、法國、義大利和西班牙透過大學醫院、專科心臟中心、結構化的臨床指南和完善的保險報銷體系，保持著強大的心臟影像影像能力，並日益重視低劑量CT方案、MRI的普及、影像引導介入治療以及減少診斷瓶頸。澳洲將基於指南的影像檢查與高品質的公立和私立心臟護理服務相結合，而韓國則擁有強大的數位化醫院基礎設施、先進的導管室能力以及對影像技術創新的快速應用。加拿大的公共醫療保健系統強調實證醫學應用、區域心臟影像影像網路以及跨省最佳化的醫療服務取得。俄羅斯在主要城市擁有先進的心血管中心，但區域差異和設備現代化仍然是重大挑戰。巴西和墨西哥正在主要大都市地區推廣先進的冠狀動脈影像檢查，私營部門的醫療能力往往超過公共醫療保健的普及速度，但兩國都面臨著如何為更廣泛的人群提供及時診斷的挑戰。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的創新技術，以提高診斷準確性、工作流程效率、病人安全性和在整個冠心病診療路徑中的整合性。醫療設備策略應著重於低劑量CT影像、加速心臟磁振造影方案、攜帶式和人工智慧驅動的心臟超音波圖、定量核子醫學影像以及支援精準引導冠狀動脈介入治療的介入影像工具。供應商和醫療服務提供者應增強與PACS、心血管資訊系統、電子健康記錄和結構化報告平台的互通性，以減少工作流程中的摩擦。人工智慧的部署應得到透明檢驗、偏差評估、上市後監測、網路安全措施和臨床醫生培訓的支援。在新興市場，擴充性的解決方案，例如功能強大的超音波診斷設備、最佳化的CT方案、遠端閱片網路以及減少停機時間的服務模式，將推動其應用。採購團隊應評估總體擁有成本、運轉率、服務範圍、法規遵循、輻射計量管理、資料安全以及與現有基礎設施的兼容性。臨床領導者必須將影像技術的選擇與循證的適當性標準、多學科心臟團隊工作流程以及可衡量的結果（例如減少不必要的侵入性血管造影術、加快診斷和改進治療計劃）相一致。

基於證據的診斷影像學結果的調查方法

本執行摘要是基於以二手資料主導的研究調查方法，並參考了檢驗的公共領域和產業相關資訊來源。該方法包括對臨床指南、監管文件、同行評審的循環系統和放射學文獻、公共衛生資料集、技術評估報告、醫院影像實踐趨勢以及權威心血管疾病參考文獻的審查。研究整合了CT、MRI、超音波、核子醫學、血管造影術、血管內超音波和光學同調斷層掃描（OCT）等多種影像模式的見解，重點在於臨床應用案例、技術創新、區域醫療基礎設施和推廣障礙。區域和國家層面的解讀是基於已記錄的醫療保健系統特徵、疾病負擔指標、影像檢查的可及性、報銷環境和數位化醫療準備。本分析不提供市場規模估算、市場佔有率或預測；而是著重於對心臟疾病影像設備產業趨勢、臨床效用、技術發展和策略意義進行實證定性評估。

結論：冠狀動脈疾病影像診斷的未來方向

隨著醫療系統追求更早期的診斷、更精準的風險分層和更有效率的治療路徑，冠狀動脈疾病的診斷影像技術正變得更加精準、網路化，並與臨床實踐深度整合。心臟CT、MRI、心臟超音波圖圖、核子醫學掃描術診斷、血管攝影、血管造影術（IVUS）、光學相干斷層掃描（OCT）以及人工智慧驅動的分析技術的進步，正在重塑臨床醫生檢測冠狀動脈疾病、評估缺血、表徵斑塊以及指導介入治療的方式。不同地區的部署狀況差異顯著，成熟的醫療系統著重於最佳化和數位化整合，而新興系統則優先考慮可近性、經濟性、人才儲備和基礎設施韌性。產業發展的最大機會在於檢驗的人工智慧、低劑量、高通量成像、可互通的平台、擴充性的服務模式以及符合實證心血管醫學的成像流程。那些能夠兼顧臨床可靠性、嚴格遵守監管規定、確保數位安全並以工作流程為中心的創新的機構，將最有能力支持下一代冠狀動脈疾病診斷技術的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟疾病診斷影像設備市場：依設備類型分類

  • 侵入式影像診斷設備
    • 血管內超音波（IVUS）系統
    • 光學同調斷層掃描（OCT）系統
    • 血流儲備分數（FFR）影像系統
    • 近紅外線光譜（NIRS）系統
  • 非侵入性影像診斷設備

第8章：心臟疾病診斷影像設備市場：依技術分類

  • 基於X光的影像診斷
  • 基於超音波的診斷成像
  • 磁振造影技術
  • 核醫學影像技術
  • 光學成像

第9章：心臟疾病診斷影像設備市場：依便攜性分類

  • 固定式診斷影像系統
  • 移動式醫療影像系統
  • 攜帶式手持設備

第10章：心臟疾病診斷影像設備市場：依應用領域分類

  • 冠狀動脈疾病的診斷
  • 術前計劃
  • 術後監測
  • 風險評估
  • 緊急心臟護理

第11章：心臟疾病診斷影像設備市場：依最終用戶分類

  • 門診部
  • 診斷中心
  • 醫院
  • 專科診所

第12章：心臟疾病診斷影像設備市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：心臟疾病診斷影像設備市場：依類別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章：心臟疾病診斷影像設備市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Arineta Ltd.
  • Boston Scientific Corporation
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Edwards Lifesciences Corporation
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Johnson & Johnson Services
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-8C74ADFC03A3

The Coronary Heart Disease Diagnostic Imaging Devices Market is projected to grow by USD 7.60 billion at a CAGR of 7.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.61 billion
Estimated Year [2026] USD 4.93 billion
Forecast Year [2032] USD 7.60 billion
CAGR (%) 7.41%

Coronary heart disease diagnostic imaging devices are central to early detection, risk stratification, treatment planning, and post-procedure assessment of ischemic heart disease. The device landscape spans noninvasive and invasive modalities, including computed tomography coronary angiography, cardiac magnetic resonance imaging, nuclear cardiology systems, echocardiography, intravascular ultrasound, optical coherence tomography, and angiography platforms used in catheterization laboratories. Demand is shaped by the global burden of cardiovascular disease, which remains the leading cause of death worldwide according to the World Health Organization, and by the clinical need to identify coronary artery stenosis, plaque burden, myocardial perfusion defects, wall motion abnormalities, and microvascular dysfunction with higher accuracy and lower procedural risk. The market environment is being influenced by guideline-driven adoption of anatomical and functional imaging, growing preference for minimally invasive diagnostics, improvements in detector technology, radiation dose reduction, point-of-care ultrasound, hybrid imaging, and digital workflow integration. Healthcare systems are also emphasizing earlier diagnosis, shorter hospital stays, and more efficient use of cath lab resources, positioning coronary heart disease diagnostic imaging devices as a strategic priority across hospitals, diagnostic centers, cardiology clinics, and ambulatory care settings.

Transformative Shifts in the Diagnostic Imaging Landscape

The coronary heart disease imaging landscape is undergoing a structural shift from single-modality, procedure-led diagnosis toward integrated, patient-specific imaging pathways. Coronary CT angiography is increasingly used to evaluate suspected coronary artery disease in appropriate low-to-intermediate risk populations, supported by improved spatial resolution, faster acquisition, and lower radiation exposure. Cardiac MRI continues to expand in myocardial viability, perfusion, fibrosis assessment, and inflammatory cardiomyopathy differentiation, while nuclear cardiology remains important for functional ischemia assessment, especially where stress testing and perfusion quantification are clinically indicated. In invasive imaging, intravascular ultrasound and optical coherence tomography are improving lesion characterization, stent optimization, and assessment of plaque morphology, strengthening the role of image-guided coronary intervention. The shift is also technological: photon-counting CT, advanced ultrasound probes, solid-state detectors, hybrid PET/CT and SPECT/CT systems, cloud-enabled image management, and interoperability standards are reshaping purchasing criteria. At the same time, value-based care is pushing providers to reduce unnecessary invasive angiography, optimize appropriateness criteria, and select imaging tools based on diagnostic yield, patient safety, workflow efficiency, and downstream clinical impact.

Cumulative Impact of Artificial Intelligence on Coronary Imaging

Artificial intelligence is creating cumulative impact across the coronary heart disease diagnostic imaging device ecosystem by improving image acquisition, reconstruction, segmentation, interpretation, reporting, and workflow prioritization. In CT and MRI, AI-enabled reconstruction can support shorter scan times, noise reduction, and dose optimization, while automated coronary calcium scoring, plaque quantification, chamber segmentation, and myocardial perfusion analysis can improve reproducibility and support consistent clinical reporting. In echocardiography, machine learning tools assist view classification, ejection fraction estimation, strain analysis, and image quality enhancement, helping address operator variability. In nuclear cardiology, AI is being applied to attenuation correction, perfusion defect detection, and risk classification, while invasive imaging platforms are increasingly integrating automated lumen and stent measurements for IVUS and OCT. The impact is not limited to diagnostics; AI-assisted triage can flag high-risk studies, streamline reading queues, and enable structured reporting linked to electronic health records. However, adoption depends on validated clinical performance, transparent algorithms, cybersecurity safeguards, data governance, regulatory clearance, integration with existing PACS and cardiovascular information systems, and clinician trust. As evidence accumulates, AI is expected to function less as a standalone feature and more as a core layer embedded within coronary imaging workflows.

Key Regional Insights Across Global Coronary Imaging Adoption

In Asia-Pacific, coronary heart disease diagnostic imaging adoption is supported by large patient populations, rising cardiometabolic risk factors, expansion of tertiary cardiac centers, and public-private investment in advanced CT, MRI, ultrasound, and cath lab infrastructure. Japan, China, India, South Korea, and Australia are prominent users of advanced cardiac imaging, while access gaps remain in rural and resource-constrained areas. Europe benefits from established cardiovascular care pathways, active adoption of radiation reduction protocols, cardiac CT and MRI expertise, and quality-focused procurement across public health systems, with differences across Western, Central, and Eastern Europe in access to newer platforms. North America is characterized by mature reimbursement structures, strong guideline adoption, advanced hospital networks, and broad use of coronary CT angiography, stress imaging, echocardiography, nuclear cardiology, and intravascular imaging for complex coronary intervention. Latin America shows growing investment in cardiology diagnostics in Brazil, Mexico, and other urban healthcare hubs, although uneven access, equipment concentration in major cities, and budget constraints influence modality selection. Africa faces the greatest access constraints, with coronary imaging availability concentrated in urban and private-sector facilities; nonetheless, increasing focus on noncommunicable disease management is improving demand for echocardiography, CT, and scalable diagnostic solutions that fit constrained infrastructure. The Middle East is advancing through investment in tertiary hospitals, specialist cardiac centers, and digital health infrastructure, particularly in higher-income Gulf economies, while broader regional access depends on workforce development and referral network maturity.

Key Group Insights Shaping Coronary Heart Disease Imaging

NATO member countries overlap with several advanced healthcare systems in North America and Europe, where procurement priorities increasingly focus on resilient supply chains, cybersecurity, digital imaging interoperability, and standardized cardiovascular care delivery across hospital networks. G7 countries generally show high utilization of evidence-based coronary imaging, broad availability of advanced modalities, and strong emphasis on AI validation, dose management, interoperability, and clinical outcomes. BRICS countries collectively represent diverse adoption conditions: China and India are expanding capacity at scale, Brazil and South Africa are addressing access disparities between public and private systems, and Russia maintains specialized cardiovascular centers with variable regional distribution of advanced imaging. The European Union provides a highly structured environment for coronary diagnostic imaging through regulatory oversight, cross-border technology standards, health technology assessment, and guideline-based care pathways that emphasize safety, appropriateness, and quality assurance. Across ASEAN, growth in coronary heart disease diagnostic imaging is influenced by rapid urbanization, expanding private healthcare networks, and national efforts to improve noncommunicable disease care, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines showing different levels of access to CT, MRI, nuclear cardiology, and interventional imaging. In the GCC, high cardiovascular risk profiles, strong hospital infrastructure investment, and specialist cardiac programs support adoption of advanced imaging platforms, including cardiac CT, MRI, echocardiography, and cath lab-integrated imaging.

Key Country Insights for Coronary Diagnostic Imaging Devices

China is scaling coronary imaging capacity rapidly across public hospitals and high-volume cardiac centers, supported by demand for CT, ultrasound, angiography, and increasingly AI-assisted interpretation. The United States demonstrates broad adoption of coronary CT angiography, echocardiography, nuclear cardiology, cardiac MRI, angiography, IVUS, and OCT, supported by specialized cardiac centers, established accreditation practices, and rapid AI-enabled workflow integration. Japan has longstanding strength in CT technology adoption, cardiovascular imaging research, and elderly patient care pathways, while India is expanding access through metropolitan hospital networks and diagnostic chains, with echocardiography, CT, and catheterization imaging playing major roles in coronary assessment. Germany, the United Kingdom, France, Italy, and Spain maintain strong cardiac imaging capabilities through university hospitals, specialist cardiology centers, structured clinical guidance, and established reimbursement frameworks, with growing attention to low-dose CT protocols, MRI capacity, image-guided intervention, and reducing diagnostic backlogs. Australia combines guideline-based imaging use with high-quality public and private cardiology services, and South Korea shows strong digital hospital infrastructure, advanced cath lab capabilities, and fast adoption of imaging innovation. Canada's publicly funded system emphasizes evidence-based utilization, regional cardiac imaging networks, and access optimization across provinces. Russia has advanced cardiovascular centers in major cities, though regional distribution and equipment modernization remain important factors. Brazil and Mexico are expanding advanced coronary imaging in major urban centers, with private-sector capacity often ahead of public access, while both countries face the challenge of extending timely diagnostics to wider populations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves diagnostic accuracy, workflow efficiency, patient safety, and integration across the coronary care pathway. Device strategies should emphasize low-dose CT imaging, faster cardiac MRI protocols, portable and AI-enabled echocardiography, quantitative nuclear cardiology, and invasive imaging tools that support precision-guided coronary intervention. Vendors and healthcare providers should strengthen interoperability with PACS, cardiovascular information systems, electronic health records, and structured reporting platforms to reduce workflow friction. AI deployment should be supported by transparent validation, bias assessment, post-market monitoring, cybersecurity controls, and clinician training. For emerging markets, scalable solutions such as robust ultrasound systems, optimized CT protocols, remote reading networks, and service models that reduce downtime can improve adoption. Procurement teams should evaluate total cost of ownership, uptime, service coverage, regulatory compliance, dose management, data security, and compatibility with existing infrastructure. Clinical leaders should align imaging selection with evidence-based appropriateness criteria, multidisciplinary heart team workflows, and measurable outcomes such as reduced unnecessary invasive angiography, faster diagnosis, and improved treatment planning.

Research Methodology for Evidence-Based Imaging Insights

This executive summary is developed using a secondary research-led methodology grounded in verified public-domain and industry-relevant sources. The approach includes review of clinical guidelines, regulatory documentation, peer-reviewed cardiology and radiology literature, public health datasets, technology assessment reports, hospital imaging practice trends, and authoritative cardiovascular disease references. Insights were synthesized across modality categories, including CT, MRI, ultrasound, nuclear imaging, angiography, intravascular ultrasound, and optical coherence tomography, with attention to clinical use cases, technology innovation, regional healthcare infrastructure, and adoption barriers. Regional and country-level interpretations were derived from documented healthcare system characteristics, disease burden indicators, imaging access patterns, reimbursement environments, and digital health readiness. The analysis avoids market sizing, market share, and forecasting, focusing instead on evidence-backed qualitative assessment of industry dynamics, clinical utility, technology shifts, and strategic implications for coronary heart disease diagnostic imaging devices.

Conclusion: Future Direction of Coronary Heart Disease Imaging

Coronary heart disease diagnostic imaging devices are becoming more precise, connected, and clinically integrated as healthcare systems seek earlier diagnosis, better risk stratification, and more efficient treatment pathways. Advances in cardiac CT, MRI, echocardiography, nuclear imaging, angiography, IVUS, OCT, and AI-enabled analytics are reshaping how clinicians detect coronary artery disease, assess ischemia, characterize plaque, and guide intervention. Adoption varies significantly by region, with mature systems focusing on optimization and digital integration, while emerging systems prioritize access, affordability, workforce capacity, and infrastructure resilience. The strongest opportunities for industry progress lie in validated AI, low-dose and high-throughput imaging, interoperable platforms, scalable service models, and imaging pathways aligned with evidence-based cardiovascular care. Organizations that combine clinical credibility, regulatory discipline, digital security, and workflow-centered innovation will be best positioned to support the next generation of coronary heart disease diagnosis.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Coronary Heart Disease Diagnostic Imaging Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Invasive Imaging Devices
    • 7.2.1. Intravascular Ultrasound (IVUS) Systems
    • 7.2.2. Optical Coherence Tomography (OCT) Systems
    • 7.2.3. Fractional Flow Reserve (FFR) Imaging Systems
    • 7.2.4. Near-Infrared Spectroscopy (NIRS) Systems
  • 7.3. Non-Invasive Imaging Devices

8. Coronary Heart Disease Diagnostic Imaging Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. X-ray Based Imaging
  • 8.3. Ultrasound-Based Imaging
  • 8.4. Magnetic Resonance Technology
  • 8.5. Nuclear Imaging Technology
  • 8.6. Optical Imaging

9. Coronary Heart Disease Diagnostic Imaging Devices Market, by Portability

  • 9.1. Introduction
  • 9.2. Fixed Imaging Systems
  • 9.3. Mobile Imaging Systems
  • 9.4. Portable Handheld Devices

10. Coronary Heart Disease Diagnostic Imaging Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnosis of Coronary Artery Disease
  • 10.3. Pre-operative Planning
  • 10.4. Post-operative Monitoring
  • 10.5. Risk Assessment
  • 10.6. Emergency Cardiac Care

11. Coronary Heart Disease Diagnostic Imaging Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care Centers
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals
  • 11.5. Specialty Clinics

12. Coronary Heart Disease Diagnostic Imaging Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Coronary Heart Disease Diagnostic Imaging Devices Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Coronary Heart Disease Diagnostic Imaging Devices Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Arineta Ltd.
  • 16.3. Boston Scientific Corporation
  • 16.4. Bracco Imaging S.p.A.
  • 16.5. Canon Medical Systems Corporation
  • 16.6. Cardinal Health, Inc.
  • 16.7. Carestream Health, Inc.
  • 16.8. Edwards Lifesciences Corporation
  • 16.9. Esaote S.p.A.
  • 16.10. FUJIFILM Holdings Corporation
  • 16.11. GE HealthCare Technologies Inc.
  • 16.12. Hitachi, Ltd.
  • 16.13. Hologic, Inc.
  • 16.14. Johnson & Johnson Services
  • 16.15. Konica Minolta, Inc.
  • 16.16. Koninklijke Philips N.V.
  • 16.17. Medtronic plc
  • 16.18. Mindray Bio-Medical Electronics Co., Ltd.
  • 16.19. Neusoft Medical Systems Co., Ltd.
  • 16.20. Positron Corporation
  • 16.21. Samsung Medison Co., Ltd.
  • 16.22. Shimadzu Corporation
  • 16.23. Siemens Healthineers AG
  • 16.24. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INVASIVE IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INVASIVE IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INVASIVE IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVASCULAR ULTRASOUND (IVUS) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVASCULAR ULTRASOUND (IVUS) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVASCULAR ULTRASOUND (IVUS) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FRACTIONAL FLOW RESERVE (FFR) IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FRACTIONAL FLOW RESERVE (FFR) IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FRACTIONAL FLOW RESERVE (FFR) IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEAR-INFRARED SPECTROSCOPY (NIRS) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEAR-INFRARED SPECTROSCOPY (NIRS) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEAR-INFRARED SPECTROSCOPY (NIRS) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-INVASIVE IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-INVASIVE IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-INVASIVE IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL X-RAY BASED IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL X-RAY BASED IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL X-RAY BASED IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND-BASED IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND-BASED IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND-BASED IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEAR IMAGING TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEAR IMAGING TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEAR IMAGING TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPTICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FIXED IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FIXED IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FIXED IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MOBILE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MOBILE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MOBILE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSIS OF CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSIS OF CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSIS OF CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PRE-OPERATIVE PLANNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PRE-OPERATIVE PLANNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PRE-OPERATIVE PLANNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POST-OPERATIVE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POST-OPERATIVE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POST-OPERATIVE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RISK ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RISK ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RISK ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EMERGENCY CARDIAC CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EMERGENCY CARDIAC CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EMERGENCY CARDIAC CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 126. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 161. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 183. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. JAPAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 190. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. INDIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GERMANY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED KINGDOM CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 211. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. AUSTRALIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 218. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. FRANCE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 225. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. SOUTH KOREA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 232. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. ITALY CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 246. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. RUSSIA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY INVASIVE IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 267. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 270. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025